
Elige tu etiqueta
se ve directamente en el vialReta + Cagri Blend
GLP-1
- Envío desde Alemania
Pedido
- DHL con seguimiento
- Embalaje discreto
De un vistazo
Reta + Cagri Blend en cifras
Las cifras clave de nuestra enciclopedia.
Entrada completa de la enciclopedia- Class
- Triple agonistGLP-1 / GIP / glucagon, + amylin analog
- Half-life
- Retatrutide around 6 dayscagrilintide around 7 to 8 days
- Form
- Lyophilisatepowder, reconstituted with BAC water
- Sizes
- 30 mg1 size in the shop
What studies show
All 5 sources in the lexicon- up to24.2 %Jastreboff et al., NEJM, 2023
- Sanyal et al., Nature Medicine, 2024
- Lau et al., The Lancet, 2021
Reseñas
Lo que dicen los clientes
Solo pedidos reales que incluían Reta + Cagri Blend.
Todas las reseñasTodavía no hay ningún análisis de laboratorio de Reta + Cagri Blend. Vota por élHazlo analizar tú mismo, pagamos la mitadTodos los análisis de laboratorio
Conocimiento
Todo sobre Reta + Cagri Blend
Información detallada próximamente.
Dosificación
Cargando información de dosificación …
Conviene tenerlo
Lo que necesitas con ello
El agua bacteriostática se añade automáticamente a tu carrito. Jeringas y toallitas con un clic.
Jeringas de insulina
10 uds. · 5.50 €
Toallitas con alcohol
50 uds. · 10 €
¿Cuánta agua?
Unidades en la jeringa para tu tamaño de vial.
Abrir calculadora →Is the Reta + Cagri Blend approved or studied?
No. As of 26 October 2026 the registry ClinicalTrials.gov lists no trial with Retatrutide and cagrilintide together. Both components are in phase 3 and not approved.
Why Retatrutide and cagrilintide together?
Both act on different satiety pathways: Retatrutide on GLP-1, GIP and glucagon, cagrilintide on amylin receptors. With semaglutide as the partner, weight loss in a phase 1b trial after 20 weeks was 17.1 instead of 9.8 percent. For Retatrutide as the partner there are no data.
What do the studies of the components show?
Retatrutide alone: in TRIUMPH-1 after 80 weeks 25.0 percent less body weight on average at the highest study dose, 3.9 percent on placebo. Cagrilintide alone: up to 10.8 percent after 26 weeks in phase 2, 3.0 percent on placebo. In a substudy liver fat also fell sharply on Retatrutide.
Why is the cagrilintide share so small?
The vial contains five times as much Retatrutide as cagrilintide, because Retatrutide is the stronger and limiting part. Anyone going by the Retatrutide share stays far below the amounts used in the cagrilintide trials. Whether the small share contributes anything has not been studied.
How long do the components stay in the body?
Retatrutide had a half-life of about six days in a phase 1b study, cagrilintide 159 to 195 hours in another study, so about a week. Both fit one dose per week.
Which side effects were seen with the components?
With both, mainly gastrointestinal effects such as nausea and diarrhoea, depending on the dose. On Retatrutide heart rate rose in a dose-dependent way in phase 2. Two satiety signals together may strengthen nausea at the start, this has not been measured for this blend.
Which trials are still running?
Nine phase 3 trials of Retatrutide are running, the largest on heart and kidney events until 2029. The RENEW trials of cagrilintide alone run until 2027. No trial of the blend is listed in the registry.
Relacionados
Productos relacionados
Tirzepatide
Péptidos · GLP-1 y pérdida de grasa GLP-1 y pérdida de grasa
10 tamaños
Analizado en laboratorio
= desde 10 €/vial
Retatrutide
Péptidos · GLP-1 y pérdida de grasa GLP-1 y pérdida de grasa
11 tamaños
Analizado en laboratorio
= desde 16 €/vial
Semaglutide
Péptidos · GLP-1 y pérdida de grasa GLP-1 y pérdida de grasa
6 tamaños
Analizado en laboratorio
= desde 10 €/vial
Mazdutide
Péptidos · GLP-1 y pérdida de grasa GLP-1 y pérdida de grasa
2 tamaños
= desde 32 €/vial
Reta + Cagri Blend